WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 317373
Description: Carisoprodol is discontinued (DEA controlled substance). Carisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands. It is slightly soluble in water and freely soluble in ethanol, chloroform and acetone. The drug's solubility is practically independent of pH. Although carisoprodol has significant pharmacological activity, its benefit in therapy is likely due mostly to the meprobamate metabolite as meprobamate remains in the system significantly longer and reaches a higher peak plasma concentration than the parent drug a few hours following administration. This is further evidenced by carisoprodol's ability to maintain relevant benefits when administered 3-4 times a day despite its short half-life of only two hours.
MedKoo Cat#: 317373
Chemical Formula: C12H24N2O4
Exact Mass: 260.17361
Molecular Weight: 260.32996
Elemental Analysis: C, 55.36; H, 9.29; N, 10.76; O, 24.58
Carisoprodol is discontinued. (DEA controlled substance.)
Synonym: Carisoprodol, Soma, Sanoma, Carisoma
IUPAC/Chemical Name: [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
InChi Key: OFZCIYFFPZCNJE-UHFFFAOYSA-N
InChi Code: InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)
SMILES Code: O=C(OCC(C)(COC(N)=O)CCC)NC(C)C
The following data is based on the product molecular weight 260.32996 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Masoner JR, Kolpin DW, Furlong ET, Cozzarelli IM, Gray JL. Landfill leachate
as a mirror of today's disposable society: Pharmaceuticals and other contaminants
of emerging concern in final leachate from landfills in the conterminous United
States. Environ Toxicol Chem. 2015 Nov 12. doi: 10.1002/etc.3219. [Epub ahead of
print] PubMed PMID: 26562222.
2: Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM. Controlled Substance
Prescribing Patterns - Prescription Behavior Surveillance System, Eight States,
2013. MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
PubMed PMID: 26469747.
3: Sullivan MD. What are we treating with opioid and sedative-hypnotic
combination therapy? Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):893-5. doi:
10.1002/pds.3821. Epub 2015 Jun 22. PubMed PMID: 26098538.